⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

November 1, 2021JAMAOpen Access

Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection

Diana Zhong Shaoming Xiao Amanda K. Debes Emily Egbert Patrizio Caturegli Elizabeth Colantuoni Aaron M. Milstone

View Full Paper

Ask AI

Bookmark

Share

Abstract

This study examines antibody durability in individuals who received an mRNA SARS-CoV-2 vaccine with prior SARS-CoV-2 infection vs those without infection.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhong et al. (2021) studied this question.

synapsesocial.com/papers/6a9da6b03ad19a20338b26ff https://doi.org/10.1001/jama.2021.19996

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Covid-19 Breakthrough Infections in Vaccinated Health Care WorkersCase-Control Study · 2021 · 1,345 citations
2Clinical Validity of Serum Antibodies to SARS-CoV-2Retrospective Study · 2020 · 46 citations
3Association of Vaccine Type and Prior SARS-CoV-2 Infection With Symptoms and Antibody Measurements Following Vaccination Among Health Care WorkersOriginal Research · 2021 · 51 citations
4Extended interval BNT162b2 vaccination enhances peak antibody generation in older peopleCohort Study · 2021 · 74 citations
5Analysis Asks: Are GLP-1 Drugs Safe in People With Frailty?JAMA · 2026

Is the Pennsylvania Measles Outbreak the New Normal?JAMA · 2026
Intensive BP Lowering Reduces Cardiovascular Risk in Adults With CKDJAMA · 2026
Wagering on Unfinished Experiments—Prediction Markets and Clinical Trial IntegrityJAMA · 2026
Massachusetts Marketplace Disenrollment Following Enhanced Subsidy ExpirationJAMA · 2026
Horses With StripesJAMA · 2026

More from Johns Hopkins University

More from Johns Hopkins Medicine